|
| Press Releases |
|
 |
|
| Sunday, September 26, 2021 |
|
|
Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin |
| Hua Medicine (2552.HK) announced that at the 6th China BioMed Innovation & Investment Conference (CBIIC), Professor Jianhua MA, Director, Department of Endocrinology, Nanjing First Hospital, Standing Member of the Chinese Diabetes Society, as one of the principal researchers presented the results from a clinical study called DREAM, which showed that dorzagliatin, a glucokinase activator and a first-in-class investigational drug of Hua Medicine, may make progress in diabetes remission. more info >> |
|
|
研究者公佈有關多格列艾汀糖尿病緩解的重要研究 |
| more info >> |
|
|
研究者公布有关多格列艾汀糖尿病缓解的重要研究 |
| 华领医药（「公司」，香港联交所股份代号：2552.HK）今天宣布，在苏州举办的第六届中国医药创新与投资大会（The China BioMed Innovation and Investment Conference，以下简称CBIIC）上，中华医学会糖尿病学分会常委、南京市第一医院内分泌科主任马建华教授作为主要研究者之一，公布了一项名为DREAM的临床研究结果，研究显示华领医药全球首创新药葡萄糖激酶激活剂多格列艾汀(dorzagliatin) 有望在糖尿病缓解方面取得进展。 more info >> |
|
| Wednesday, September 15, 2021 |
|
|
华领医药与国药控股签署供应链战略合作协议 加速商业化布局 |
| 2021年9月13日，华领医药技术（上海）有限公司(「华领医药」,香港联交所股份代号：2552）与国药控股股份有限公司（「国药控股」，香港联交所股份代号：1099）签署供应链战略合作协议，将在物流仓储、供应链管理和渠道信息化等方面展开深入合作 more info >> |
|
|
華領醫藥與國藥控股簽署供應鏈戰略合作協議 加速商業化佈局 |
| 2021年9月13日，華領醫藥技術（上海）有限公司(「華領醫藥」,香港聯交所股份代號：2552）與國藥控股股份有限公司（「國藥控股」，香港聯交所股份代號：1099）簽署供應鏈戰略合作協議，將在物流倉儲、供應鏈管理和渠道信息化等方面展開深入合作 more info >> |
|
|
Hua and Sinopharm Announced Supply Chain Strategic Cooperation |
| On September 13, 2021, Hua Medicine (Shanghai) Ltd. (the "Hua Medicine", Stock Code: 2552.HK) has signed a supply chain strategic cooperation agreement with Sinopharm Group Co., Ltd. (the "Sinopharm", Stock Code: 1099). more info >> |
|
| Thursday, August 19, 2021 |
|
|
华领医药公布2021年中期业绩 |
| 华领医药（「公司」，香港联交所股份代号：2552.HK），今天宣布公司及其附属公司截至2021年6月30日止，6个月（「报告期」）的综合业绩。 more info >> |
|
|
華領醫藥公佈2021年中期業績 |
| 華領醫藥（「公司」，香港聯交所股份代號：2552.HK），今天宣佈公司及其附屬公司截至2021年6月30日止，6個月（「報告期」）的綜合業績。 more info >> |
|
|
Hua Medicine Announces 2021 Interim Results |
| Hua Medicine (the "Company", Stock Code: 2552.HK), today announces the consolidated results of the Company and its subsidiaries for the six months ended June 30, 2021 (the "Reporting Period"). more info >> |
|
| Friday, April 23, 2021 |
|
|
华领医药糖尿病首创新药多扎格列艾汀NDA获NMPA受理！为全球首个葡萄糖激酶激活剂 |
| 华领医药（「公司」，香港联交所股份代号：2552.HK），今天宣布，糖尿病首创新药多扎格列艾汀( dorzagliatin)递交的NDA申请已获国家药品监督管理局（NMPA）新药审评中心（CDE）受理。多扎格列艾汀成为全球范围内首个提交新药上市申请的葡萄糖激酶激活剂类（GKA）糖尿病治疗药物，并有望成为在中国首先上市的全球首创新药（FIC）。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Bitcoin Latinum在邁阿密巴塞爾藝術展舉辦歷史性的元宇宙派對
Dec 4, 2021 15:28 HKT/SGT
|
|
|
Bitcoin Latinum在迈阿密巴塞尔艺术展举办历史性的元宇宙派对
Dec 4, 2021 15:27 HKT/SGT
|
|
|
Bitcoin Latinum Hosts Historic Miami Art Basel Metaverse Party
Dec 4, 2021 06:00: JST
|
|
|
Bitcoin Latinum Hosts Historic Miami Art Basel Metaverse Party
Dec 4, 2021 06:00 HKT/SGT
|
|
|
German Fintech Startup Paycer to Combine DeFi, Crypto with Conventional Banking Services
Dec 4, 2021 06:00 HKT/SGT
|
|
|
German Fintech Startup Paycer to Combine DeFi, Crypto with Conventional Banking Services
Dec 4, 2021 05:00: JST
|
|
|
$NOID Undergoes CertiK Audit, Guarantees Secure Transaction and Realization of Smart Contracts
Dec 4, 2021 01:00 HKT/SGT
|
|
|
Hans Energy Increases its Shareholding in the Holding Companies of Citybus and NWFB to 15.56%
Dec 3, 2021 20:06 HKT/SGT
|
|
|
Blockpass Provides Identity Verification for Radom Network's KYC & KYB Processes
Dec 3, 2021 20:00: JST
|
|
|
中天顺联复牌工作接近尾声 完成多项复牌指引
Dec 3, 2021 20:00 HKT/SGT
|
|
|
AXL INU Token Pre-sale Is Going Live Soon
Dec 3, 2021 20:00 HKT/SGT
|
|
|
汉思能源拟增持城巴及新巴之控股公司股权至15.56%
Dec 3, 2021 19:03 HKT/SGT
|
|
|
漢思能源擬增持城巴及新巴之控股公司股權至15.56%
Dec 3, 2021 19:02 HKT/SGT
|
|
|
AXL INU Token Pre-sale Is Going Live Soon
Dec 3, 2021 19:00: JST
|
|
|
Blockpass Provides Identity Verification for Radom Network's KYC & KYB Processes
Dec 3, 2021 19:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
